"オミクロン" の関連情報検索結果

What COVID-19 variants are going around in April 2025? - Nebraska Medicine Omaha, NE



What COVID-19 variants are going around in April 2025?  Nebraska Medicine Omaha, NE

Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster f...



Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19  Nature

Study Reveals 45% Of Athens’ “COVID Deaths” During Omicron Wave Were Misclassified - Greek City T...



Study Reveals 45% Of Athens’ “COVID Deaths” During Omicron Wave Were Misclassified  Greek City Times

Post-infection immunity may wane faster after SARS-CoV-2 Omicron than after previous strains - CI...



Post-infection immunity may wane faster after SARS-CoV-2 Omicron than after previous strains  CIDRAP

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence - News-Medical



Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence  News-Medical

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine



Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design  Duke University School of Medicine

Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via A...



Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering  PNAS

What Are the Symptoms of the Omicron Variant? - AARP



What Are the Symptoms of the Omicron Variant?  AARP

Omicron Symptoms Day by Day - Health. Powered by Ada.



Omicron Symptoms Day by Day  Health. Powered by Ada.

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature



Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron  Nature

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the abse...



Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology  Nature

Antiviral effect of Bromelain combined with acetylcysteine against SARS-CoV-2 Omicron variant - N...



Antiviral effect of Bromelain combined with acetylcysteine against SARS-CoV-2 Omicron variant  Nature

Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vacci...



Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections  Nature

Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines aga...



Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses | npj Viruses  Nature

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era - Nature



Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era  Nature

The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dyna...



The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dynamic features to enhance the interaction with the hACE2  Nature

A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1...



A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5  Nature

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial - Nature



Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial  Nature

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...



Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines  Nature

Children exhibit a robust B-cell response to Omicron BA.2 after breakthrough infection with limit...



Children exhibit a robust B-cell response to Omicron BA.2 after breakthrough infection with limited influence from the original antigenic sin  Nature

Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational stu...



Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study  The Lancet

T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and post...



T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and postpartum women living with and without HIV in South Africa  Nature

Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...



Genomic Surveillance for SARS-CoV-2 Variants: ...  Centers for Disease Control and Prevention | CDC (.gov)

Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysi...



Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysis  Nature

Study: COVID Omicron deaths 3 times higher than for flu, but risks for severe cases similar - CIDRAP



Study: COVID Omicron deaths 3 times higher than for flu, but risks for severe cases similar  CIDRAP

Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COV...



Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient  Nature

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...



Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation  Nature

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages...



Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages  Nature

Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vacc...



Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan  ScienceDirect.com

Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance...



Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategy  ScienceDirect.com

No increased autoimmune risk after omicron, delta COVID-19 in boosted patients - Healio



No increased autoimmune risk after omicron, delta COVID-19 in boosted patients  Healio

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutra...



Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies | Signal Transduction and Targeted Therapy  Nature

Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst...



Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst hospitalized Singaporean adults: a national cohort study  The Lancet

A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron s...



A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection  Nature

Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplif...



Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial - The Lancet Infectious Diseases  The Lancet

Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthr...



Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster  ScienceDirect.com

KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases - Centers for Disease Control ...



KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases  Centers for Disease Control and Prevention | CDC (.gov)

Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-C...



Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-CoV-2 in Vietnam  Nature

Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination - The Lancet



Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination  The Lancet

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough in...



Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection  Nature

Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Varia...



Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs  ACS Publications

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and ...



Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations  Nature

Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine



Durability of XBB.1.5 Vaccines against Omicron Subvariants  The New England Journal of Medicine

A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16,...



A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses  Nature

Computationally restoring the potency of a clinical antibody against Omicron - Nature



Computationally restoring the potency of a clinical antibody against Omicron  Nature

Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and ado...



Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China  Nature

What Is Omicron’s Incubation Period? - Verywell Health



What Is Omicron’s Incubation Period?  Verywell Health

A new COVID variant is on the rise. Here’s what to know about LP.8.1 - The Conversation



A new COVID variant is on the rise. Here’s what to know about LP.8.1  The Conversation

Association of pre-existing depression and anxiety with Omicron variant infection | Molecular Psy...



Association of pre-existing depression and anxiety with Omicron variant infection | Molecular Psychiatry  Nature

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...



Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Ga...



High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia  Nature

The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater survei...



The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater surveillance  ScienceDirect.com

Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later ...



Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants  Science | AAAS

Remember Covid? Where has it gone?! - Stuff



Remember Covid? Where has it gone?!  Stuff

Statement on Omicron sublineage BA.2 - World Health Organization (WHO)



Statement on Omicron sublineage BA.2  World Health Organization (WHO)

One year since the emergence of COVID-19 virus variant Omicron - World Health Organization (WHO)



One year since the emergence of COVID-19 virus variant Omicron  World Health Organization (WHO)

Omicron, Now 2 Years Old, Is Not Done With Us Yet (Published 2023) - The New York Times



Omicron, Now 2 Years Old, Is Not Done With Us Yet (Published 2023)  The New York Times

Paxlovid reduces serious risks from Omicron variants - National Institutes of Health (NIH) (.gov)



Paxlovid reduces serious risks from Omicron variants  National Institutes of Health (NIH) (.gov)

Symptoms and Preventions of the COVID Omicron-XBB Variant - Siloam Hospitals



Symptoms and Preventions of the COVID Omicron-XBB Variant  Siloam Hospitals

Omicron: 10 things to know about the very contagious COVID-19 variant - University of California ...



Omicron: 10 things to know about the very contagious COVID-19 variant  University of California - Davis Health

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant - The New England Jou...



Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant  The New England Journal of Medicine

Omicron infection following vaccination enhances a broad spectrum of immune responses dependent o...



Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history  Nature

JN.1 Omicron subvariant: Questions patients may have - American Medical Association



JN.1 Omicron subvariant: Questions patients may have  American Medical Association

3 Stages of COVID-19 Infection: Which Day Do You Feel Worse? - health.com



3 Stages of COVID-19 Infection: Which Day Do You Feel Worse?  health.com

What doctors wish patients knew about the BA.2 Omicron subvariant - American Medical Association



What doctors wish patients knew about the BA.2 Omicron subvariant  American Medical Association

FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants -...



FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants  Fortune

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - The New England Journal...



Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB  The New England Journal of Medicine

Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice - Nature



Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice  Nature

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant - The New England Journal ...



Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant  The New England Journal of Medicine

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants - The New England Journal of Medi...



Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants  The New England Journal of Medicine

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge - The New England Journal ...



Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge  The New England Journal of Medicine

Durability of Bivalent Boosters against Omicron Subvariants - The New England Journal of Medicine



Durability of Bivalent Boosters against Omicron Subvariants  The New England Journal of Medicine

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting - Nature



Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting  Nature

If Omicron is less severe, why are COVID-19 deaths rising? - The World Economic Forum



If Omicron is less severe, why are COVID-19 deaths rising?  The World Economic Forum

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 - The New England Journal of Medicine



A Bivalent Omicron-Containing Booster Vaccine against Covid-19  The New England Journal of Medicine

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants - The New England Journ...



Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants  The New England Journal of Medicine

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex ...



SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex  Science | AAAS

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant - The New England Jo...



Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant  The New England Journal of Medicine

Effectiveness of Bivalent Boosters against Severe Omicron Infection - The New England Journal of ...



Effectiveness of Bivalent Boosters against Severe Omicron Infection  The New England Journal of Medicine

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages - Scientific Reports - Nature



Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages - Scientific Reports  Nature

If you've had omicron before, are you safe from infection by the new variants? - NPR



If you've had omicron before, are you safe from infection by the new variants?  NPR

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies - Nature



Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies  Nature

XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association



XBB.1.5 Omicron subvariant: Questions patients may have  American Medical Association

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection - The New England Journ...



Protection against the Omicron Variant from Previous SARS-CoV-2 Infection  The New England Journal of Medicine

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy - Nature



Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy  Nature

An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation - Nature



An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation  Nature

Omicron has caused higher increase in U.S. daily death count than delta variant - PBS



Omicron has caused higher increase in U.S. daily death count than delta variant  PBS

FDA says COVID boosters for the fall must target newer omicron types - NPR



FDA says COVID boosters for the fall must target newer omicron types  NPR

What do we know so far about the Omincron sub-variant BA.2? - The World Economic Forum



What do we know so far about the Omincron sub-variant BA.2?  The World Economic Forum

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel - The New England Journal of Me...



Protection by a Fourth Dose of BNT162b2 against Omicron in Israel  The New England Journal of Medicine

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection - The New England Journal...



Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection  The New England Journal of Medicine

Omicron Boosters and Flu Shots: What to Know This Fall - Cedars-Sinai



Omicron Boosters and Flu Shots: What to Know This Fall  Cedars-Sinai

BNT162b2 Protection against the Omicron Variant in Children and Adolescents - The New England Jou...



BNT162b2 Protection against the Omicron Variant in Children and Adolescents  The New England Journal of Medicine

SARS-CoV-2 Omicron boosting induces de novo B cell response in humans - Nature



SARS-CoV-2 Omicron boosting induces de novo B cell response in humans  Nature

Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 - Science | AAAS



Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1  Science | AAAS

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...



Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  The New England Journal of Medicine

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants - Th...



Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants  The New England Journal of Medicine

Effects of Vaccination and Previous Infection on Omicron Infections in Children - The New England...



Effects of Vaccination and Previous Infection on Omicron Infections in Children  The New England Journal of Medicine

Why omicron is crushing hospitals — even though cases are often milder than delta - NPR



Why omicron is crushing hospitals — even though cases are often milder than delta  NPR

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections - The New England...



Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections  The New England Journal of Medicine